Latest news
Loading news…
Ymmuno Biotech
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Florianópolis, Santa Catarina, Brazil Founded 2019 1-10 employees For Profit
Using IgY as an oral immunotherapy for infectious disease, focused in research and development to reduce antibiotics resistance
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- IT spend
- $9M
Company Info
- Founded
- 2019
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- HQ
- Florianópolis, Santa Catarina, Brazil
- Region
- Latin America
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -0.1
Key People at Ymmuno Biotech
Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ymmuno Biotech
Loading news…
FAQs about Ymmuno Biotech
People who checked this page also checked these
Browse the full Acquirezy directory.